References
- Veis DJ, Cassat JE. Infectious osteomyelitis: marrying bone biology and microbiology to shed new light on a persistent clinical challenge. J Bone Miner Res. 2021;36(4):636–643. doi:10.1002/jbmr.4279
- Valdezate S, Garrido N, Carrasco G, et al. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain. J Antimicrob Chemother. 2017;72(3):754–761. doi:10.1093/jac/dkw489
- Jiao M, Deng X, Yang H, et al. Case report: a severe and multi-site nocardia farcinica infection rapidly and precisely identified by metagenomic next-generation sequencing. Front Med. 2021;8:669552. doi:10.3389/fmed.2021.669552
- Hamdi AM, Fida M, Deml SM, et al. Retrospective analysis of antimicrobial susceptibility profiles of nocardia species from a tertiary hospital and reference laboratory, 2011 to 2017. Antimicrob Agents Chemother. 2020;64(3):e01868–19. doi:10.1128/AAC.01868-19
- Lebeaux D, Bergeron E, Berthet J, et al. Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010–2015. Clin Microbiol Infect. 2019;25(4):489–495. doi:10.1016/j.cmi.2018.06.013
- Bansal Y, Singla N, Butta H, et al. Nocardia infections: ten years experience from a tertiary health care center in North India (2007–2016). Infect Disord Drug Targets. 2021;21(3):445–451. doi:10.2174/1871526520666200516161940
- Wang H, Zhu Y, Cui Q, et al. Epidemiology and antimicrobial resistance profiles of the nocardia species in China, 2009 to 2021. Microbiol Spectr. 2022;10(2):e0156021. doi:10.1128/spectrum.01560-21
- Pan L, Wang XH, Meng FQ, et al. Membranous nephropathy complicated with disseminated nocardia farcinica infection: a case report and literature review. Infect Drug Resist. 2021;14:4157–4166. doi:10.2147/IDR.S331737
- Vemu L, Sudhaharan S, Mamidi N, et al. Need for appropriate specimen for microbiology diagnosis of chronic osteomyelitis. J Lab Physicians. 2018;10(1):21–25. doi:10.4103/JLP.JLP_14_17
- Weheba I, Abdelsayed A, Alrajhi AA, et al. Nocardiosis at an organ transplant center in Saudi Arabia: 15 years’ experience. J Glob Infect Dis. 2021;13(1):7–12. doi:10.4103/jgid.jgid_66_20
- Ding J, MA B, Wei X, et al. Detection of Nocardia by 16S Ribosomal RNA Gene PCR and Metagenomic Next-Generation Sequencing (mNGS). Front Cell Infect Microbiol. 2021;11:768613. doi:10.3389/fcimb.2021.768613
- Weng SS, Zhang HY, Ai JW, et al. Rapid detection of nocardia by next-generation sequencing. Front Cell Infect Microbiol. 2020;10:13. doi:10.3389/fcimb.2020.00013
- Woods GL, Brown-Elliott BA, CONVILLE PS, et al. CLSI Standards: guidelines for Health Care Excellence [M]. In: Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes. Wayne (PA): Clinical and Laboratory Standards Institute; 2011.
- Toyokawa M, Ohana N, Ueda A, et al. Identification and antimicrobial susceptibility profiles of Nocardia species clinically isolated in Japan. Sci Rep. 2021;11(1):16742. doi:10.1038/s41598-021-95870-2
- Bury DC, Rogers TS, Dickman MM. Osteomyelitis: diagnosis and Treatment. Am Fam Physician. 2021;104(4):395–402.
- Tripathi S, Meena DS, Rohila AK, et al. Empyema necessitans with osteomyelitis of fifth rib due to Nocardia farcinica: a case report. BMC Infect Dis. 2021;21(1):745. doi:10.1186/s12879-021-06452-6
- Young P, Riga A, Brunelli J. Nocardia nova infection of tibia tenodesis implant after anterior cruciate ligament reconstruction in an immunocompetent patient. J Am Acad Orthop Surg Glob Res Rev. 2020;4(3):e19.00167. doi:10.5435/JAAOSGlobal-D-19-00167